JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. JW (Cayman) Therapeutics Co's Free Cash Flow for the six months ended in Dec. 2023 was $0.00 Mil. JW (Cayman) Therapeutics Co's Revenue for the six months ended in Dec. 2023 was $0.00 Mil. Therefore, JW (Cayman) Therapeutics Co's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, JW (Cayman) Therapeutics Co's current FCF Yield % is -50.53%.

The historical rank and industry rank for JW (Cayman) Therapeutics Co's FCF Margin % or its related term are showing as below:

JWCTF' s FCF Margin % Range Over the Past 10 Years
Min: -2267.52 Med: -437.4 Max: -237.55
Current: -288.66

During the past 6 years, the highest FCF Margin % of JW (Cayman) Therapeutics Co was -237.55%. The lowest was -2267.52%. And the median was -437.40%.

JWCTF's FCF Margin % is ranked worse than
58.95% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs JWCTF: -288.66

JW (Cayman) Therapeutics Co FCF Margin % Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co FCF Margin % Chart

JW (Cayman) Therapeutics Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-2,267.63

-437.40

-237.55

JW (Cayman) Therapeutics Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial						-1,056.28	-604.67	-298.87	-279.13	-

Competitive Comparison of JW (Cayman) Therapeutics Co's FCF Margin %

For the Biotechnology subindustry, JW (Cayman) Therapeutics Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW (Cayman) Therapeutics Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JW (Cayman) Therapeutics Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where JW (Cayman) Therapeutics Co's FCF Margin % falls into.

JW (Cayman) Therapeutics Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

JW (Cayman) Therapeutics Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-57.841	/	24.349
	=	-237.55 %

JW (Cayman) Therapeutics Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0
	=	%

JW (Cayman) Therapeutics Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

02126:Hong Kong

Address

No. 699 Zhong Ke Road, 5F, Building B, Pudong New District, Shanghai, CHN

Website

https://www.jwtherapeutics.com

JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co (JW (Cayman) Therapeutics Co) Headlines

No Headlines